of interaction with the genomic DNA. While some messenger RNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the disadvantage of requiring... 78 KB (7,926 words) - 15:19, 26 April 2024 |
subgroup of genetic vaccines encompass viral vector vaccines, RNA vaccines and DNA vaccines.[citation needed] Viral vector vaccines use a safe virus to... 139 KB (14,389 words) - 19:40, 15 April 2024 |
infected. There are other vaccine candidates in development including live attenuated, inactivated, DNA and subunit vaccines. In December 2018, Dengvaxia... 39 KB (3,733 words) - 03:19, 31 March 2024 |
Marburg virus (redirect from RVSV-MARV vaccine) Marburg virus vaccine was conducted in 2014. The study tested a DNA vaccine and concluded that individuals inoculated with the vaccine exhibited some... 51 KB (4,925 words) - 13:33, 20 November 2023 |
COVID-19 vaccines such as Florida surgeon general Joseph Ladapo have claimed that trace amounts of contaminant DNA present alongside the vaccine's mRNA could... 6 KB (591 words) - 13:21, 26 April 2024 |
[non-primary source needed] DNA vaccine approaches for dental cavities have had a history of success in animal models. Dental cavity vaccines directed to key components... 12 KB (1,267 words) - 05:50, 14 April 2024 |
template for developing vaccines and therapeutics against a MERS-CoV infection. As of March 2020, there was one (DNA-based) MERS vaccine that completed Phase I... 192 KB (21,930 words) - 19:29, 15 April 2024 |
not been linked to Guillain–Barré syndrome. Hepatitis B vaccines are produced with recombinant DNA techniques and contain immunologic adjuvant. They are... 57 KB (5,164 words) - 14:40, 9 April 2024 |